BECN1 and rectal carcinoma: In 96 cases of rectal carcinoma, increased beclin-1 expression predicted a significantly reduced pathological response (macroscopic versus microscopic or no residual tumor) to chemoradiation (high: 14.2 % vs. low: 40 %; P = 0.017).